Chemical Risk Factors of Primary Liver Cancer: An Update
Adam Barsouk,1 Krishna Chaitanya Thandra,2 Kalyan Saginala,3 Prashanth Rawla,4 Alexander Barsouk5 1Sidney Kimmel Cancer Center, Jefferson University, Philadelphia, PA 19107, USA; 2Department of Pulmonary and Critical Care Medicine, Sentara Virginia Beach General Hospital, Virginia Beach, VA, USA; 3P...
Guardado en:
Autores principales: | Barsouk A, Thandra KC, Saginala K, Rawla P |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8245468a2c0e48d4a56542b70e0c9e17 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development of a Model to Predict Liver Decompensation prior to Transarterial Chemoembolization Refractoriness in Patients with Intermediate-Stage Hepatocellular Carcinoma
por: Joel Ferreira-Silva, et al.
Publicado: (2021) -
An excerpt of EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update
por: ZHANG Yue
Publicado: (2021) -
Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
por: Baur J, et al.
Publicado: (2016) -
Transmission, diagnosis, and management of hepatitis E: an update
por: Mirazo S, et al.
Publicado: (2014) -
Update on entecavir in the management of severe forms of Hepatitis B
por: Sacco R
Publicado: (2012)